Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-alpha therapy

Durk Fekkes1, Arthur R Van Gool, Marjolein Bannink

  • 1Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands. d.fekkes@erasmusmc.nl

Amino Acids
|October 28, 2008
PubMed

Insights

Interferon-alpha (IFN-alpha) treatment alters nitric oxide (NO) and monoamine oxidase (MAO) levels in cancer patients. Peripheral NO production and MAO activity appear unrelated and unlikely to cause psychiatric side effects.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Interferon-alpha (IFN-alpha) treatment in cancer patients has conflicting reports on nitric oxide (NO) synthesis.
  • Animal studies suggest IFN-alpha influences biogenic amines, monoamine oxidases (MAOs), and subsequently NO production via hydrogen peroxide (H2O2).

Purpose of the Study:

  • To investigate the relationship between plasma NO production and platelet MAO-B activity in cancer patients receiving IFN-alpha.
  • To assess biochemical changes during IFN-alpha therapy and their potential link to psychopathology.

Main Methods:

  • Quantified NO synthesis by measuring citrulline/arginine ratio (CIT/ARG-ratio) and total nitrite/nitrate (NOx) levels.
  • Assessed MAO-B activity in platelets of 43 cancer patients over an 8-week IFN-alpha treatment period.

Main Results:

  • MAO activity and NOx levels increased significantly compared to baseline.
  • The CIT/ARG-ratio decreased during IFN-alpha treatment.
  • No significant associations were found between NOx, MAO activity, and the CIT/ARG-ratio.
  • Few links between biochemical changes and psychopathology were observed, with changes in citrulline (CIT) and lassitude being the most consistent.

Conclusions:

  • Peripheral NO production and MAO activity are not directly related in patients treated with IFN-alpha.
  • Observed peripheral biochemical changes are unlikely to be the primary cause of significant psychiatric disturbances during IFN-alpha therapy.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...